| SKU | Size | Availability | Price | Qty |
|---|---|---|---|---|
| R106321-250mg | 250mg | Available within 4-8 weeks(?) Items will be manufactured post-order and can take 4-8 weeks. Thank you for your patience! | $206.90 |
| Synonyms | Retinoic acid|tretinoin|302-79-4|all-trans-Retinoic acid|Vitamin A acid|trans-Retinoic acid|ATRA|Renova|Retin-A|Vesanoid|Aberel|Eudyna|Airol|All-trans Retinoic Acid|all-trans-Vitamin A acid|Dermairol|Aknefug|Aknoten|Atralin|Cordes vas|Epi-aberel|TRETINON| |
|---|---|
| Specifications & Purity | Moligand™, analytical standard |
| Biochemical and Physiological Mechanisms | Description: IC50 Value: N/A All-trans retinoic acid (ATRA) has been widely investigated for treatments of many cancers including prostate cancer. in vitro: ATRA was able to induce the growth arrest and to increase HOXB13 expression in AR |
| Storage Temp | Store at -20°C |
| Shipped In | Ice chest + Ice pads |
| Grade | analytical standard, Moligand™ |
| Action Type | AGONIST, ANTAGONIST |
| Mechanism of action | Retinoic acid receptor agonist |
| ALogP | 6.3 |
|---|
| IUPAC Name | (2E,4E,6E,8E)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenoic acid |
|---|---|
| INCHI | InChI=1S/C20H28O2/c1-15(8-6-9-16(2)14-19(21)22)11-12-18-17(3)10-7-13-20(18,4)5/h6,8-9,11-12,14H,7,10,13H2,1-5H3,(H,21,22)/b9-6+,12-11+,15-8+,16-14+ |
| InChi Key | SHGAZHPCJJPHSC-YCNIQYBTSA-N |
| Canonical SMILES | CC1=C(C(CCC1)(C)C)C=CC(=CC=CC(=CC(=O)O)C)C |
| Isomeric SMILES | CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)O)/C)/C |
| WGK Germany | 2 |
| RTECS | VH6475000 |
| PubChem CID | 444795 |
| Molecular Weight | 300.44 |
| Beilstein | 2057223 |
| Reaxy-Rn | 2057223 |
Enter Lot Number to search for COA:
To view the certificate results,please click on a Lot number.For Lot numbers from past orders,please use our order status section
| Lot Number | Certificate Type | Date | Item |
|---|---|---|---|
 F1828090 | Certificate of Analysis | Nov 07, 2023 | R106321 |
| L2103040 | Certificate of Analysis | Sep 18, 2023 | R106321 |
| F1821031 | Certificate of Analysis | Feb 22, 2022 | R106321 |
| Melt Point(°C) | 180-181°C |
|---|
| Pictogram(s) | GHS08, GHS07 |
|---|---|
| Signal | Danger |
| Hazard Statements | H315:Causes skin irritation H319:Causes serious eye irritation H335:May cause respiratory irritation H360:May damage fertility or the unborn child |
| Precautionary Statements | P261:Avoid breathing dust/fume/gas/mist/vapors/spray. P305+P351+P338:IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present and easy to do - continue rinsing. P280:Wear protective gloves/protective clothing/eye protection/face protection. P302+P352:IF ON SKIN: wash with plenty of water. P321:Specific treatment (see ... on this label). P405:Store locked up. P501:Dispose of contents/container to ... P264:Wash hands [and …] thoroughly after handling. P271:Use only outdoors or in a well-ventilated area. P304+P340:IF INHALED: Remove person to fresh air and keep comfortable for breathing. P403+P233:Store in a well-ventilated place. Keep container tightly closed. P362+P364:Take off contaminated clothing and wash it before reuse. P203:Obtain, read and follow all safety instructions before use. P264+P265:Wash hands [and …] thoroughly after handling. Do not touch eyes. P318:if exposed or concerned, get medical advice. P337+P317:If eye irritation persists: Get medical help. P332+P317:If skin irritation occurs: Get medical help. P319:Get medical help if you feel unwell. |
| WGK Germany | 2 |
| RTECS | VH6475000 |
| Reaxy-Rn | 2057223 |
| Merck Index | 8165 |
| 1. Charton J, Deprez-Poulain R, Hennuyer N, Tailleux A, Staels B, Deprez B. (2009) Novel non-carboxylic acid retinoids: 1,2,4-oxadiazol-5-one derivatives.. Bioorg Med Chem Lett, 19 (2): (489-92). [PMID:19058965] |
